Marketmen tracking the sector are anticipating higher allocation towards production linked incentive (PLI) schemes for the healthcare sector for capacity building of sensitive APIs, complex excipients, drug intermediates, biopharmaceuticals and medical devices.Marketmen tracking the sector are anticipating higher allocation towards production linked incentive (PLI) schemes for the healthcare sector for capacity building of sensitive APIs, complex excipients, drug intermediates, biopharmaceuticals and medical devices.Read More
